PLAAT3 and familial pancreatic carcinoma: Furthermore, patients with pancreatic cancer exhibiting high PLA2G16 expression demonstrated notably shorter OS (Fig. 2B) and disease-free survival (Fig. 2C) periods compared to those with low PLA2G16 expression.